Cardiac myofibrillar and sarcoplasmic reticulum function are not depressed in insulin-resistant JCR:LA-cp rats

被引:25
|
作者
Misra, T
Gilchrist, JSC
Russell, JC
Pierce, GN
机构
[1] St Boniface Gen Hosp, Res Ctr, Div Stroke & Vasc Dis, Winnipeg, MB R2H 2A6, Canada
[2] Univ Manitoba, Dept Oral Biol, Winnipeg, MB R2H 2A6, Canada
[3] Univ Manitoba, Dept Physiol, Winnipeg, MB R2H 2A6, Canada
[4] Univ Alberta, Dept Surg, Edmonton, AB T6G 2S2, Canada
关键词
contractile proteins; calcium; diabetic cardiomyopathy; excitation-contraction coupling; myosin; cardiomyocytes; non-insulin-dependent diabetes mellitus; insulin;
D O I
10.1152/ajpheart.1999.276.6.H1811
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Depressed myofibrillar Ca2+-ATPase activity and sarcoplasmic reticulum (SR) Ca2+ uptake are important mechanisms that are responsible for the cardiac dysfunction exhibited by insulin-deficient (type I) diabetic animals. The JCR:LA-cp rat is a model for type II non-insulin-dependent diabetes mellitus (NIDDM). This rat is insulin resistant, obese, and has high levels of circulating glucose, cholesterol, insulin, and triglycerides. The purpose of this study was to determine whether changes in cardiac myofibrillar, SR, and cardiomyocyte function exist in this model of type II diabetes. Myofibrils and SR were isolated from hearts by differential centrifugation. Surprisingly, we found that myofibrillar Ca2+-ATPase activities were unaltered in these animals. Ca2+ uptake in isolated SR fractions was increased in diabetic cp/cp rats, whereas Ca2+-ATPase activity and ryanodine binding were unchanged. Cardiomyocytes isolated from hearts of control and experimental animals had similar active cell shortening and intracellular Ca2+ concentration under basal conditions and in response to caffeine. Our data argue against the presence of a cardiomyopathy in this diabetic model and suggest that insulin may be an important factor in the cardiomyopathy observed in type I diabetic models.
引用
收藏
页码:H1811 / H1817
页数:7
相关论文
共 50 条
  • [1] Postischemic cardiac performance in the insulin-resistant JCR : LA-cp rat
    Maddaford, TG
    Russell, JC
    Pierce, GN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (03): : H1187 - H1192
  • [2] Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats
    Wascher, TC
    Wölkart, G
    Russell, JC
    Brunner, F
    [J]. DIABETES, 2000, 49 (05) : 803 - 809
  • [3] Vascular wall function in insulin-resistant JCR:LA-cp rats:: Role of male and female sex
    O'Brien, SF
    Russell, JC
    Dolphin, PJ
    Davidge, ST
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (02) : 176 - 181
  • [4] Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats
    McKendrick, JD
    Salas, E
    Dubé, GP
    Murat, J
    Russell, JC
    Radomski, MW
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (02) : 361 - 369
  • [5] Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats
    Russell, J. C.
    Kelly, S. E.
    Vine, D. F.
    Proctor, S. D.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (06) : 1588 - 1596
  • [6] Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats
    Wang, ZQ
    Zhang, XH
    Russell, JC
    Hulver, M
    Cefalu, WT
    [J]. JOURNAL OF NUTRITION, 2006, 136 (02): : 415 - 420
  • [7] A novel complex of arginine–silicate improves micro- and macrovascular function and inhibits glomerular sclerosis in insulin-resistant JCR:LA-cp rats
    S. D. Proctor
    S. E. Kelly
    J. C. Russell
    [J]. Diabetologia, 2005, 48 : 1925 - 1932
  • [8] Vascular function in resistance arteries in JCR:LA-cp rats: A model of insulin resistance
    OBrien, SF
    Davidge, ST
    Russell, JC
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 39 - 39
  • [9] Beneficial insulin-sensitizing and vascular effects of s15261 in the insulin-resistant JCR:LA-cp rat
    Russell, JC
    Ravel, D
    Pegorier, JP
    Delart, P
    Jochemsen, R
    O'Brien, SF
    Kelly, SE
    Davidge, ST
    Brindley, DN
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (02): : 753 - 760
  • [10] A novel complex of arginine-silicate improves micro- and macrovascular function and inhibits glomerular sclerosis in insulin-resistant JCR:LA-cp rats
    Proctor, SD
    Kelly, SE
    Russell, JC
    [J]. DIABETOLOGIA, 2005, 48 (09) : 1925 - 1932